The Trigger of the First Trial Effect: examing pure Sensory Polyneuropathy Patients

The Trigger of the First Trial Effect: examing pure Sensory Polyneuropathy Patients - FTE in Polyneuropathy Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36041

Enrollment

Registered

2011-06-21

Start date

2011-04-15

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensory Polyneuropathy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Symmetric, sensoric, distal polyneuropathy Diabets Mellitus typ I patients defined as: absence of achillestendon reflex, distal ' sock' gnostic sensoric loss.

Exclusion criteria

Exclusion criteria: - neurological diseases other than proprioceptic loss in the feet, lower legs and hands - orthopedic diseases - vestibular diseases - severe vision disturbances on 1 or 2 eyes (with glasses): vision below 5/60 = able to count the fingers of the examiner at 5 meters distance - other diseases with a potentiel abnormal or disadvantageous effect on the equilibrium - sedic medication - bloodpressure lowering medication - pregnancy - age under 18 years - Body Mass Index above 25kg/m2

Design outcomes

Primary

Measure	Time frame
1. Balance of sensory polyneuropathy in patients compared with that of healthy control subjects (expressed in Center of Mass movement that occurs after the platform tilts).	—

Secondary

Measure	Time frame
- Body movements based on 18 different points of limbs, trunk and pelvic tilts of the platform with polyneuropathy in patients compared to healthy controls. - Muscle activity of ten muscles during tilts of the platform measured using surface electromyography.	—

Countries

Netherlands

Outcome results